Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection

Inhaled administration of ethanol in the early stages of COVID-19 would favor its location on the initial replication sites, being able to reduce the progression of the disease and improving its prognosis. Before evaluating the efficacy and safety of this novel therapeutic strategy in humans, its ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro-Balado, Ana, Mondelo-García, Cristina, Barbosa-Pereira, Letricia, Varela-Rey, Iria, Novo-Veleiro, Ignacio, Vázquez-Agra, Néstor, Antúnez-López, José Ramón, Bandín-Vilar, Enrique José, Sendón-García, Raquel, Busto-Iglesias, Manuel, Rodríguez-Bernaldo de Quirós, Ana, García-Quintanilla, Laura, González-Barcia, Miguel, Zarra-Ferro, Irene, Otero-Espinar, Francisco J., Rey-Bretal, David, Lago-Quinteiro, José Ramón, Valdés-Cuadrado, Luis, Rábade-Castedo, Carlos, del Río-Garma, María Carmen, Crespo-Diz, Carlos, Delgado-Sánchez, Olga, Aguiar, Pablo, Barbeito-Castiñeiras, Gema, Pérez del Molino-Bernal, María Luisa, Trastoy-Pena, Rocío, Passannante, Rossana, Llop, Jordi, Pose-Reino, Antonio, Fernández-Ferreiro, Anxo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999202/
https://www.ncbi.nlm.nih.gov/pubmed/33808025
http://dx.doi.org/10.3390/pharmaceutics13030342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999202/
https://www.ncbi.nlm.nih.gov/pubmed/33808025
http://dx.doi.org/10.3390/pharmaceutics13030342

Ejemplares similares